CareTrust REIT, Inc. (CTRE) Form 8-K — Aug 6, 2026
CareTrust REIT (NYSE: CTRE) reported record Q2 2026 results: net income of $89.0 million ($0.38 per diluted share, up 9% YoY), Normalized FFO of $119.7 million ($0.51 per share, up 19% YoY), and Normalized FAD of $118.5 million ($0.51 per share, up 19%), on total revenues of $161.3 million, up 43% year over year. The company closed $899.6 million of investments in the quarter at an 8.9% blended stabilized yield, lifting year-to-date deployment to roughly $1.5 billion at about 8.7%, with a $540 million pipeline. Management raised full-year 2026 guidance to Normalized FFO of $2.03-$2.06 per share and Normalized FAD of $2.01-$2.04 per share, with midpoints up 16.2% and 15.1% over 2025.
Key figures
- Eps
- 0.38
- Revenue
- 161348000
- Guidance
- Raised FY2026: net income $1.53-$1.56/share; Normalized FFO $2.03-$2.06/share (midpoint +16.2% vs 2025); Normalized FAD $2.01-$2.04/share (midpoint +15.1%); assumes 233 million weighted-average diluted shares, 2.5% rent escalators, and no new investments/issuances beyond YTD
- Net Income
- 89000000
- Total Debt
- 1210000000
- Revenue Yoy
- 43%
- Total Assets
- 5929251000
- Cash Position
- 90000000
- Shares Outstanding
- approximately 233 million weighted-average diluted shares assumed in 2026 guidance (234.2 million diluted WA in Q2 2026)
- Rent collection
- 100% of contractual rent and interest
- Normalized fad q2
- $118.5 million ($0.51/share, +19% YoY)
- Normalized ffo q2
- $119.7 million ($0.51/share, +19% YoY)
- Atm q2 settlements
- $363.6 million gross proceeds
- Dividend per share
- 0.39
- Investment pipeline
- $540 million
- Ytd 2026 deployment
- approximately $1.5 billion at roughly 8.7% blended yield
- Dividend payout ratio
- approximately 76% of Normalized FAD
- Revolver availability
- $605 million available under $1.2 billion unsecured revolver as of August 6, 2026
- Q2 investment activity
- $899.6 million at 8.9% blended stabilized yield
- Post quarter investments
- $307.9 million at 7.8% blended stabilized yield
- May 2026 forward offering
- 14.4 million shares at $40.23 weighted average price for $578.2 million gross proceeds
- Provision for loan losses q2
- 4671000
- Forward equity proceeds outstanding
- $671 million unsettled under equity forward contracts
- Net debt to annualized run rate ebitda
- 1.01x
Price after filing
Close on the filing date to close N calendar days later (from $40.84). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.